Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Different concentrations of nalbuphine combined with hydromorphone for PCIA after cesarean section
ChiCTR1800015014Phase 4Recruiting
- Sponsor
- Women's Hospital, Zhejiang University School of Medicine
- Start
- Feb 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of nalbuphine and hydromorphone in postoperative pain (3 arms), sponsored by Women's Hospital, Zhejiang University School of Medicine. Primary endpoints: VAS score of uterine contraction pain, VAS score of incisional pain and 2 more. Started Feb 2018; status: recruiting.
02
Drugs
nalbuphinehydromorphone
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR1800015014.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800015014.